← Eichor
Condition: Resistance Bacterial Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Resistance Bacterial

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administ
Phase 1/Phase 2 · 8 location(s) · SNIPR Biome Aps. · NCT06938867Hotspots, Households and Hospitals: Enhanced Drug-resistant Tuberculosis Case Finding in Namibia
Phase N/A · 1 location(s) · University of Namibia · NCT05022238Radiotherapy for Refractory Hidradenitis Suppurativa
NA · 2 location(s) · Thomas Jefferson University · NCT07414550SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
NA · 1 location(s) · University of Washington · NCT05286931A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.
Phase N/A · 2 location(s) · Nantes University Hospital · NCT07234331Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 2/Phase 3 · 6 location(s) · University of California, San Francisco · NCT06441006Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tube
Phase 3 · 5 location(s) · Huashan Hospital · NCT05081401Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
Phase 3 · 5 location(s) · Lund University · NCT05224401Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
NA · 1 location(s) · University of California, San Francisco · NCT05553236Urine Metabolites in the Diagnosis of Disease
Phase N/A · 4 location(s) · Luventix, Inc. · NCT06710067Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth
Phase 1 · 2 location(s) · McMaster Children's Hospital · NCT05967871Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of M
Phase 2 · 11 location(s) · Janssen Research & Development, LLC · NCT02354014Training Protocol on the Natural History of Tuberculosis
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01212003A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · 17 location(s) · Locus Biosciences · NCT05488340Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
Phase 4 · 3 location(s) · Rambam Health Care Campus · NCT05922124Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
NA · 2 location(s) · University of California, Berkeley · NCT06824350Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children
Phase 2 · 1 location(s) · University of Virginia · NCT07451171Linezolid Plus Standard of Care
NA · 12 location(s) · University Hospital, Basel, Switzerland · NCT06958835The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gast
NA · 1 location(s) · Nimble Science Ltd. · NCT06317441Combined Lactulose H2-breath Test With Abdominal Imaging
Phase N/A · 1 location(s) · Klinik Arlesheim · NCT07145580A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871Indiana University Gastrointestinal Motility Diagnosis Registry
Phase N/A · 1 location(s) · Indiana University · NCT04506593STI Prophylaxis and Emergence of Antimicrobial Resistance
Phase N/A · 1 location(s) · University College, London · NCT06778083Herbal Evaluation Of Artemisia Annua For Small Intestinal Bacterial Overgrowth
Phase 1/Phase 2 · 1 location(s) · National University of Natural Medicine · NCT06721884A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bact
NA · 1 location(s) · Henan University of Traditional Chinese Medicine · NCT07206745Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalospori
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07345923Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05153824Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs
NA · 1 location(s) · University Hospital, Caen · NCT05872152Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumo
Phase N/A · 1 location(s) · Fujian Medical University Union Hospital · NCT07086391
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.